Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Altimmune, Inc.Listing on record | Exercise | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Altimmune, Inc.Listing on record | Other | $35K | SEC | ||
Altimmune, Inc.Listing on record | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Synvista Therapeutics, Inc.Listing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Synvista Therapeutics, Inc.Listing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
X4 Pharmaceuticals, IncListing on record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
X4 Pharmaceuticals, IncListing on record | Sell | $5.2K | SEC | ||
X4 Pharmaceuticals, IncListing on record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
X4 Pharmaceuticals, IncListing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
X4 Pharmaceuticals, IncListing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
X4 Pharmaceuticals, IncListing on record | AwardD (derivative) | $1.6M | SEC | ||
Tempest Therapeutics, Inc.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Tempest Therapeutics, Inc.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |